Stock Research: KORU Medical Systems

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

KORU Medical Systems

NasdaqCM:KRMD US7599101026
78
  • Value
    37
  • Growth
    99
  • Safety
    Safety
    21
  • Combined
    67
  • Sentiment
    46
  • 360° View
    360° View
    78
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

KORU Medical Systems, Inc. is a medical technology company focused on patient-centric large volume subcutaneous infusion solutions for drug delivery. Its main business is mechanical infusion products, including the FREEDOM Infusion Systems. In the last fiscal year, the company had a market cap of $138 million, profits of $21 million, revenue of $34 million, and 80 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 78 (better than 78% compared with alternatives) for 2024, overall professional sentiment and financial characteristics for the stock KORU Medical Systems are very positive. The 360° View is based on consolidating four consolidated indicators, with three out of four indicators below average for KORU Medical Systems. The consolidated Growth Rank has a good rank of 99, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth, as well as stock returns. It ranks higher than 99% of competitors in the same industry. The other indicators are below average, namely the Value, Safety, and Sentiment Ranks.The Value Rank at 21 means that the share price of KORU Medical Systems is on the high side compared with its peers regarding revenues, profits, and invested capital. The stock price is higher than for 79% of alternative stocks in the same industry. The consolidated Safety Rank has a riskier rank of 37, which means that the company has a riskier financing structure than 63% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. The consolidated Sentiment Rank also has a low rank of 46, indicating professional investors are more pessimistic about the stock than for 54% of alternative investment opportunities. ...read more

more
Index
NASDAQ
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 21-Aug-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Growth
Shows a company's growth potential.
High Growth Tough Times
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
21 25 40 43
Growth
99 100 59 31
Safety
Safety
37 37 65 65
Sentiment
46 60 51 41
360° View
360° View
78 78 81 19
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
41 38 61 8
Opinions Change
77 50 50 50
Pro Holdings
n/a 48 1 51
Market Pulse
63 85 85 70
Sentiment
46 60 51 41
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
21 25 40 43
Growth
99 100 59 31
Safety Safety
37 37 65 65
Combined
67 67 9 9
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
52 52 52 52
Price vs. Earnings (P/E)
30 31 51 45
Price vs. Book (P/B)
15 18 48 48
Dividend Yield
1 1 1 1
Value
21 25 40 43
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
80 66 59 57
Profit Growth
96 94 51 1
Capital Growth
61 100 91 69
Stock Returns
97 100 31 37
Growth
99 100 59 31
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
78 87 76 83
Refinancing
21 20 43 63
Liquidity
21 21 49 49
Safety Safety
37 37 65 65

Similar Stocks

Discover high‑ranked alternatives to KORU Medical Systems and broaden your portfolio horizons.

Micron

NasdaqGS:MU
Country: USA
Industry: Semiconductors
Size: X-Large
Full Stock Analysis

Meta

NasdaqGS:FB
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Alphabet

NasdaqGS:GOOG.L
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Lithia Motors

NYSE:LAD
Country: USA
Industry: Automotive Retail
Size: X-Large
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.